Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, ...

Courage Therapeutics Inc. and University of Michigan have synthesized peptides acting as melanocortin MC4 receptor (MC4R) agonists and/or MC3 receptor (MC3R) antagonist/partial agonists reported to be ...

Synthekine Doses First Patient in Phase 1 Clinical Trial of IL-2 Partial Agonist, STK-012, for Treatment of Solid Tumors February 03, 2022 08:00 AM Eastern Standard Time ...

GCSE OCR Muscular system - OCR Agonist and antagonist muscle pairs This system is mainly concerned with producing movement through muscle contraction. This section explores the different types of ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today presented new data from preclinical studies of STK-026, its biased IL-12 partial agonist ...